IRWD FY 2021 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$629M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$414M+6.2% YoY

Gross Profit

$343M83.0% margin

Operating Income

$232M56.1% margin

Net Income

$528M127.7% margin

EPS (Diluted)

$3.21

Cash Flow

Operating Cash Flow

$262M

Free Cash Flow

$262M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$521M

Stockholders' Equity

$606M

Cash & Equivalents

$620M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$414M	$390M	+6.2%
Gross Profit	$343M	$386M	-11.1%
Operating Income	$232M	$143M	+62.5%
Net Income	$528M	$106M	+397.7%